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Abstract 
Fluorinated acetonitrile oxides, generated from the corresponding hydroximoyl bromides in the 
presence of aryl, hetaryl, ferrocenyl, and cycloaliphatic thioketones, undergo efficient [3+2]-cycloadditions to 
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no competitive formation of furoxans as dimers of the intermediate 1,3-dipoles.  
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Due to the importance of fluorinated heterocycles, the elaboration of efficient methods for their 
synthesis is a challenging task. The [3+2]-cycloadditions offer a versatile approach to diverse five-membered 
heterocycles [1]. Among the most frequently used classical 1,3-dipolar species, nitrile oxides are easily available 
and have been shown to react with both electron-rich and electron-deficient dipolarophiles (class II according to 
Sustmann [2], i.e., HOMO(Dipole)/LUMO(Dipolarophile) and LUMO(Dipole)/HOMO(Dipolarophile) interactions are of 
importance). Nitrile oxides 1a, derived from aromatic nitriles, are the most well-known class of these 1,3-
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dipoles. On the other hand, trifluoroacetonitrile oxide (1b), reported for the first time in 1971 [3,4], has rarely 
been used in [3+2]-cycloadditions, which are limited to reactions with alkenes and alkynes [3,5]. 
In our ongoing studies on applications of thioketones in cycloaddition chemistry, we demonstrated that 
they react as ‘superdipolarophiles’ and ‘superdienophiles’ yielding five- and six-membered S-heterocycles, 
respectively [6]. Thiobenzophenone (2a) and adamantanethione (2e) were reported to undergo [3+2]-
cycloadditions with aromatic nitrile oxides 1a to give the respective 1,4,2-oxathiazoles 3 in a regioselective 
manner [7] (Scheme 1). 
 
 
Scheme 1. [3+2]-Cycloadditions of aryl nitrile oxides 1a with thioketones 2. 
 
 The interest of 1,4,2-oxathiazoles increased in recent years as they were shown to be useful precursors 
of isothiocyanates as products of their thermal fragmentation [7b,8]. In addition, some of them were studied as 
analogues of 1,2,4-thiadiazoles known as anticancer ‘lead molecules’ [9]. 
  
 The goal of the present study was the preparation of hitherto unknown 3-trifluoromethyl and 3-
difluoromethyl substituted 1,4,2-oxathiazoles via [3+2]-cycloaddition of fluorinated nitrile oxides 1b and 1c 




Figure 1. Aryl, hetaryl, ferrocenyl, and cycloaliphatic thioketones 2a–f. 
2. Results and discussion 
The fluorinated nitrile oxides 1b and 1c were generated in situ by treatment of their precursors, i.e. 
hydroximoyl bromides 4a [5c] and 4b with triethylamine (TEA) in diethyl ether (Et2O) at room temperature in 
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the presence of equimolar amounts of thioketone 2 (Scheme 2). In all reactions, the characteristic color of 2 
disappeared rapidly and the reactions were complete in a few minutes. In a typical experiment with 
thiobenzophenone (2a) and trifluoroacetonitrile oxide (1b), after typical workup and chromatographic 
purification, a yellowish product was obtained and identified as the expected [3+2]-cycloadduct 5a in 95% yield. 
 
Scheme 2. Generation of fluoroalkyl nitrile oxides 1b,c and their [3+2]-cycloadditions with thioketones 2a–f. 
 
The spectroscopic data of 5a were in agreement with those of similar 5,5-diphenyl-1,4,2-oxathiazoles 
reported in [8b]. Thus, the diagnostic 
13
C NMR signals for C(5) and C(3) appear at 112.8 and 148.1 ppm, 
respectively. The characteristic quartet of the CF3 group was found at 118.7 ppm (
1
JC,F = 273.8 Hz). In the 
19
F 
NMR spectrum, the signal of this group was found at –63.4ppm. 
All experiments performed with 1b and 1c using thioketones 2 as dipolarophiles led to the 






Figure 2. Aryl, hetaryl, ferrocenyl, and spirocyclic 1,4,2-oxathiazoles 5a–l prepared according to Scheme 2. 
 
The high reactivity of thioketones towards fluorinated nitrile oxides 1 is demonstrated by the fact that in 
none of the studied cases the formation of dimers of the 1,3-dipole, i.e. bis(trifluoromethyl)furoxan [5b], was 
observed. Furthermore, in all experiments 1,4,2-oxathiazoles were formed regioselectively, and the presence of 
fluoroalkyl groups does not affect the type of the transition state of the [3+2]-cycloaddition. In recent 
publications we demonstrated that [3+2]-cycloadditions of hetaryl thioketones with electron-rich thiocarbonyl S-
methanides follow a stepwise mechanism and delocalized diradicals are postulated as key intermediates [10]. 
Their appearance governs the observed regiochemistry resulting in the formation of sterically crowded 4,4,5,5-
tetrasubstituted 1,3-dithiolanes. In contrast, it seems likely that the reactions of thioketones with electron 
deficient fluorinated nitrile oxides, irrespective of the type of the thioketone, occur as concerted processes; in the 
transition states of the studied reactions there are no structural features, which could favor formation of 
diradicals or zwitterions via known stabilizing effects.  
3. Conclusions 
The presented results show that 3-fluoroalkylated 1,4,2-oxathiazoles can be efficiently prepared via the 
regioselective [3+2]-cycloaddition of in situ generated fluorinated nitrile oxides with ‘superdipolarophilic’ 
thioketones. The reactions occur with no competitive dimerization of the highly reactive 1,3-dipoles. In addition 
to the recently reported synthesis of fluoroalkylated 1,2,4-thiadiazole derivatives via 1,3-dipolar cycloadditions 
of nitrile imines with C=S dipolarophiles [11], the present study confirmed the utility of thioketones as versatile 





4.1. General information 
 Solvents and chemicals were purchased and used as received without further purification. Fluoral 
hydrate (75%), difluoroacetaldehyde ethyl hemiacetal (90%) and hydroxylamine hydrochloride were purchased 
from FluoroChem. NBS was purchased from TCI Chemicals. Aryl (2a) [12], hetaryl (2b,c) [13], ferrocenyl (2d)
 
[14], and cycloaliphatic (2e) [15a] and (2f) [15b] thioketones were prepared following the literature procedures 
by thionation of the corresponding ketones by using Lawesson’s reagent or tetraphosphorus decasulfide (P4S10). 
Tri- and difluoroacetaldehyde oximes were prepared following the literature procedure by condensation of a 
small excess of fluoral hydrate or difluoroacetaldehyde ethyl hemiacetal with hydroxylamine hydrochloride in 
MeOH/H2O solution, in the presence of NaOH, at 0 °C [5c]. The corresponding bromides were prepared 
following the described procedure of bromination of oximes with application of NBS [5c]. Products were 
purified by standard column chromatography on silica gel (230–400 mesh, Merck). Unless stated otherwise, 
yields refer to analytically pure samples. NMR spectra were recorded with Bruker Avance III 600 MHz (
1
H 
NMR [600 MHz]; 
13
C NMR [151 MHz]) or with a Varian Gemini 2000BB 200 MHz (
19
F NMR [188 MHz]) 
instrument. Chemical shifts are reported relative to solvent residual peaks (
1H NMR: δ = 7.26 ppm [CDCl3]; 13C 
NMR: δ = 77.0 ppm [CDCl3]). For detailed peak assignments 2D HMQC spectra were measured. IR spectra 
were registered with a FTIR NEXUS spectrometer (as film or KBr pellets). High-resolution MS spectra were 
performed with a GCT Premier Waters instrument. Melting points were determined in capillaries with a Stuart 
SMP30 apparatus with automatic temperature monitoring.  
 
4.2. General procedure for the synthesis of fluoroalkylated 1,4,2-oxathiazoles 5a–l 
 
An etheral solution of the respective hydroximoyl bromide 4a [5c] or 4b (10 mL, 1.0 mmol) was added 
dropwise to a solution of thioketone 2 (1.0 mmol) and Et3N (202 mg, 2.0 mmol) in Et2O (3–4 mL) under an Ar 
atmosphere until the color of the starting thioketone disappeared (typically up to 10 min). The precipitate of 
triethylamine hydrobromide was filtered off, and the solvents were removed under reduced pressure. The 
resulting mixture was purified by column chromatography (SiO2) using a mixture of petroleum 
ether/dichloromethane, up to 100% of dichloromethane, as the eluent. 
 
4.2.1. 5,5-Diphenyl-3-(trifluoromethyl)-1,4,2-oxathiazole (5a). Yield: 294 mg (95%). Pale-yellow oil. IR (film): 
 3111–2830 (=CH, CH), 1569 (C=N), 1446, 1335, 1215-1130 (CF3), 1033, 973, 753 cm–1. 1H NMR (CDCl3):  
7.44–7.45 (m, 6H, Ph), 7.56–7.58 (m, 4H, Ph). 13C NMR (CDCl3):  112.8 (s, C(2)), 118.7 (q, 1JC,F = 273.8 Hz, 
CF3), 127.0 (s, 4CH, Ph), 128.5 (s, 4CH, Ph), 129.5 (s, 2CH, Ph), 139.8 (s, 2C, Ph), 148.1 (q, 
2
JC,F = 39.1 Hz, 
C(4)). 
19
F NMR (CDCl3):  –63.42 (s, CF3). HRMS/EI: m/z calcd. for C15H10F3NOS 309.043519; found 
309.0438 [100]. 
 
4.2.2. 3-(Difluoromethyl)-5,5-diphenyl-1,4,2-oxathiazole (5b). Yield: 216 mg (74%). Colorless oil. IR (film):  





JH,F = 53.7 Hz, 1H, CHF2), 7.42–7.43 (m, 6H, Ph), 7.55–7.56 (m, 4H, Ph). 13C NMR (CDCl3):  109.0 
(t, 
1
JC,F = 240.1 Hz, CHF2), 110.8 (s, C(2)), 127.0 (s, 4CH, Ph), 128.4 (s, 4CH, Ph), 129.2 (s, 2CH, Ph), 140.3 (s, 
2C, Ph), 152.4 (q, 
2
JC,F = 31.4 Hz, C(4)). 
19
F NMR (CDCl3):  –115.48 (d, 2JF,H = 53.4 Hz, CHF2). HRMS/EI: 
m/z calcd. for C15H11F2NOS 291.052941; found 291.0533 [100]. 
 
4.2.3. 5-Phenyl-5-(thiophen-2-yl)-3-(trifluoromethyl)-1,4,2-oxathiazole (5c). Yield: 278 mg (88%). Yellow oil. 
IR (film):  3133–2836 (=CH, CH), 1569 (C=N), 1446, 1330, 1212–1137 (CF3), 1033, 961 cm–1. 1H NMR 
(CDCl3):  7.00–7.01 (m, 2H, Th), 7.47–7.48 (m, 3H, Ph), 7.49–7.50 (m, 1H, Th), 7.63–7.65 (m, 2H, Ph). 13C 
NMR (CDCl3):  109.0 (s, C(2)), 118.5 (q, 1JC,F = 273.9 Hz, CF3), 126.1 (s, 2CH, Ph), 127.0 (s, 1CH, Th), 128.4 
(s, 2CH, Ph), 129.2 (s, 1CH, Ph), 129.7 (s, 1CH, Th), 129.9 (s, 1CH, Th), 140.1 (s, 1C, Ph), 143.2 (s, 1C, Th), 
148.1 (q, 
2
JC,F = 39.2 Hz, C(4)). 
19
F NMR (CDCl3):  –63.66 (s, CF3). HRMS/EI: m/z calcd. for C13H8F3NOS2 
314.999939; found 314.9999 [100]. 
 
4.2.4. 3-(Difluoromethyl)-5-phenyl-5-(thiophen-2-yl)-1,4,2-oxathiazole (5d). Yield: 256 mg (86%). Pale-green 
oil. IR (film):  3133–2840 (=CH, CH), 1571 (C=N), 1352, 1113–1045 (CHF2), 961, 772 cm–1.  1H NMR 
(CDCl3):  6.53 (t, 2JH,F(1) = 2JH,F(2) = 53.6 Hz, 1H, CHF2), 6.99–7.02 (m, 2H, Th), 7.45–7.48 (m, 4H, Ph), 7.63–
7.64 (m, 1H, Th), 7.65–7.66 (m, 1H, Ph). 13C NMR (CDCl3):  107.0 (s, C(2)), 108.9 (t, 1JC,F(1) = 1JC,F(2) = 240.3 
Hz, CHF2), 126.2 (s, 2CH, Ph), 126.9 (s, 1CH, Th), 128.3 (s, 2CH, Ph), 128.8 (s, 1CH, Ph), 129.4 (s, 1CH, Th), 




JC,F(2) =31.5 Hz, C(4)). 
19
F NMR 
(CDCl3):  –114.53 (dd, 2JH,F = 53.6 Hz, 2JF,F = 318.0 Hz, 1F, CHF2), –116.56 (dd, 2JH,F = 53.6 Hz, 2JF,F = 318.0 
Hz, 1F, CHF2). HRMS/EI: m/z calcd. for C13H9F2NOS2 297.009361; found 297.0090 [100]. 
 
4.2.5. 5-Phenyl-5-(selenophen-2-yl)-3-(trifluoromethyl)-1,4,2-oxathiazole (5e). Yield: 311 mg (86%). Yellow 
oil. IR (film):  3126–2836 (=CH, CH), 1564 (C=N), 1446, 1330, 1233, 1216–1130 (CF3), 1033, 956, 746 cm–1.  
1
H NMR (CDCl3):  7.17–7.18 (m, 1H, Sel), 7.23–7.25 (m, 1H, Sel), 7.46–7.48 (m, 3H, Ph), 7.66–7.69 (m, 2H, 
Ph), 8.20–8.21 (m, 1H, Sel). 13C NMR (CDCl3):  110.8 (s, C(2)), 118.5 (q, 1JC,F = 274.0 Hz, CF3), 126.1 (s, 
2CH, Ph), 128.4 (s, 2CH, Ph), 129.4 (s, 1CH, Ph), 129.7 (s, 1CH, Sel), 132.1 (s, 1CH, Sel), 135.1 (s, 1CH, Sel), 
140.1 (s, 1C, Ph), 148.2 (q, 
2
JC,F = 39.2 Hz, C(4)), 149.8 (s, 1C, Sel). 
19
F NMR (CDCl3):  –63.64 (s, CF3). 
HRMS/EI: m/z calcd. for C13H8F3NOSSe 362.944390; found 362.9449, 360.9463 [100, 60]. 
 
4.2.6. 3-(Difluoromethyl)-5-phenyl-5-(selenophen-2-yl)-1,4,2-oxathiazole (5f). Yield: 258 mg (75%). Yellow oil. 
IR (film):  3131–2840 (=CH, CH), 1548 (C=N), 1448, 1360, 1236, 1111–1035 (CHF2), 958, 768, 693 cm–1. 1H 
NMR (CDCl3):  6.53 (t, 2JH,F(1) = 2JH,F(2) = 53.6 Hz, 1H, CHF2), 7.17–7.18 (m, 1H, Sel), 7.22–7.24 (m, 1H, Sel), 





JC,F(2) = 240.4 Hz, CHF2), 126.2 (s, 2CH, Ph), 128.3 (s, 2CH, Ph), 129.3 (s, 1CH, Ph), 129.5 




JC,F(2) = 31.6 Hz, C(4)). 
19





JH,F = 53.6 Hz,
 2
JF,F = 317.3 Hz, 1F, CHF2). HRMS/EI: m/z calcd. for C13H9F2NOSSe 344.953812; found 
344.9541, 342.9541 [100, 95]. 
 
4.2.7. 5-Ferrocenyl-5-methyl-3-(trifluoromethyl)-1,4,2-oxathiazole (5g). Yield: 291 mg (82%). Dark-red solid, 





H NMR (CDCl3):  2.24 (s, 3H, Me), 4.26 (s, 5H, Fc), 4.35 (s, 1H, Fc), 4.38 (s, 1H, Fc), 4.40 (s, 1H, Fc), 
4.52 (s, 1H, Fc). 
13
C NMR (CDCl3):  29.0 (s, Me), 67.5 (s, 1CH, Fc), 68.2 (s, 1CH, Fc), 69.6 (s, 5CH, Fc), 69.7 
(s, 1CH, Fc), 69.9 (s, 1CH, Fc), 85.8 (s, 1C, Fc), 109.5 (s, C(2)), 118.7 (q, 
1
JC,F = 273.4 Hz, CF3), 147.0 (q, 
2
JC,F 
= 38.6 Hz, C(4)). 
19
F NMR (CDCl3):  –63.93 (s, CF3). HRMS/EI: m/z calcd. for C14H12F3FeNOS 354.994111; 
found 354.9945 [100]. 
 
4.2.8. 3-(Difluoromethyl)-5-ferrocenyl-5-methyl-1,4,2-oxathiazole (5h). Yield: 194 mg (58%). Dark-brown oil. 
IR (film):  3143–2840 (=CH, CH), 1564 (C=N), 1376, 1273, 1122–981 (CHF2), 921, 822, 741  cm–1. 1H NMR 





JH,F(2) = 53.8 Hz, 1H, CHF2). 
13
C NMR (CDCl3):  29.0 (s, Me), 67.4 (s, 1CH, Fc), 68.2 (s, 








JC,F(2) = 31.6 Hz, C(4)). 
19
F NMR (CDCl3):  –113.96 (dd, 
2
JH,F = 53.8 Hz, 
2
JF,F = 315.7 Hz, 1 F, CHF2), –117.02 (dd, 2JH,F = 53.8 Hz, 2JF,F = 315.7 Hz, 1 F, CHF2). 
HRMS/EI: m/z calcd. for C14H13F2FeNOS 337.003533; found 337.0038 [100]. 
 
4.2.9. 3-(Trifluoromethyl)adamantane-2-spiro-5’-(1,4,2-oxathiazole) (5i). Yield: 204 mg (70%). Pale-yellow oil. 
IR (film):  3007–2830 (=CH, CH), 1572 (C=N), 1453, 1335, 1268, 1191–1155 (CF3), 1029, 980, 935 cm–1. 1H 
NMR (CDCl3):  1.65–1.70 (m, 6H, Adamantyl), 1.81–1.83 (m, 2H, Adamantyl), 1.89–1.91 (m, 2H, 
Adamantyl), 2.19–2.21 (m, 2H, Adamantyl), 2.39 (brs, 2H, Adamantyl). 13C NMR (CDCl3):  25.9, 26.6, 33.5, 
36.8, 37.0, 39.6  (6s, 10C, Adamantyl), 117.5 (s, spiro-C), 119.0 (q, 
1
JC,F = 273.3 Hz, CF3), 147.6 (q, 
2
JC,F = 38.4 
Hz, C(4)). 
19
F NMR (CDCl3):  –64.14 (s, CF3). HRMS/EI: m/z calcd. for C12H14F3NOS 277.074819; found 
277.0750 [100]. 
 
4.2.10. 3-(Difluoromethyl)adamantane-2-spiro-5’-(1,4,2-oxathiazole) (5j). Yield: 206 mg (80%). Yellow oil. IR 
(film):  3005–2827 (=CH, CH), 1572 (C=N), 1452, 1363, 1241, 1109–1035 (CHF2), 978, 923, 774 cm–1. 1H 
NMR (CDCl3):  1.73–1.76 (m, 2H, Adamantyl), 1.80–1.83 (m, 4H, Adamantyl), 1.89–1.93 (m, 2H, 
Adamantyl), 1.97–2.00 (m, 2H, Adamantyl), 2.29–2.30 (m, 2H, Adamantyl), 2.44 (brs, 2H, Adamantyl), 6.48 (t, 
2
JH,F = 53.8 Hz, 1H, CHF2). 
13
C NMR (CDCl3):   26.0, 26.7, 33.6, 36.9, 37.0, 39.6  (6s, 10C, Adamantyl), 109.3 
(t, 
1
JC,F = 239.1 Hz, CHF2), 115.2 (s, spiro-C), 152.0 (t, 
2
JC,F = 31.1 Hz, C(4)). 
19
F NMR (CDCl3):  –115.83 (d, 
2
JF,H = 53.6 Hz, CHF2). HRMS/EI: m/z calcd. for C12H15F2NOS 259.084241; found 259.0845 [100]. 
 
4.2.11. 1,1,3,3-Tetramethyl-7-(trifluoromethyl)-5-oxa-8-thia-6-azaspiro[3.4]oct-6-en-2-one (5k). Yield: 157 mg 
(59%). Pale-yellow oil. IR (film):  3020–2830 (=CH, CH), 1788 (C=O), 1580 (C=N), 1462, 1230–1100 (CF3), 
8 
 




H NMR (CDCl3):  1.26 (s, 6H, 2 Me), 1.27 (s, 6H, 2 Me). 13C NMR (CDCl3):  
18.2 (s, 2 Me), 23.3 (s, 2 Me), 67.1 (s, 2 C(Me)2), 113.2 (s, spiro-C), 118.6 (q, 
1
JC,F = 273.6 Hz, CF3), 147.1 (q, 
2
JC,F = 39.3 Hz, C(4)), 215.7 (s, C=O). 
19
F NMR (CDCl3):  –63.72 (s, CF3). HRMS/EI: m/z ([M–
dimethylketene]
+
) calcd. for C6H6F3NOS 197.012219; found 197.0120 [100]. 
 
4.2.12. 7-(Difluoromethyl)-1,1,3,3-tetramethyl-5-oxa-8-thia-6-azaspiro[3.4]oct-6-en-2-one (5l). Yield: 224 mg 
(90%). Pale-pink oil. IR (film):  = 3008–2844 (=CH, CH), 1790 (C=O), 1579 (C=N), 1464, 1365, 1245, 1099, 
1092, 1083–1012 (CHF2), 917, 776 cm–1. 1H NMR (CDCl3):  1.32 (s, 6H, 2 Me), 1.33 (s, 6H, 2 Me), 6.52 (t, 
2
JH,F = 53.5 Hz, 1H, CHF2). 
13
C NMR (CDCl3):  18.2 (s, 2 Me), 23.3 (s, 2 Me), 66.9 (s, 2 C(Me)2), 108.7 (t, 
1
JC,F = 239.8 Hz, CHF2), 111.2 (s, spiro-C), 151.5 (t, 
2
JC,F = 31.6 Hz, C(4)), 216.5 (s, C=O). 
19
F NMR (CDCl3):  
–115.69 (d, 2JF,H = 53.3 Hz, CHF2). HRMS/EI: m/z ([M–dimethylketene]+) calcd. for C6H7F2NOS 179.021640; 
found 179.0216 [100]. 
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